Bausch Health Announces 2024 Annual Meeting of Shareholder Results

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) has disclosed the outcomes of its 2024 annual shareholders' meeting. The event saw all 10 director nominees successfully elected, as voted by shareholders at the meeting conducted on May 14, 2024. Shareholders also passed a non-binding advisory vote approving executive compensation and an amendment to increase the number of shares under the Company's 2014 Omnibus Incentive Plan. Additionally, PricewaterhouseCoopers LLP has been appointed as the Company's independent auditor until the next annual meeting in 2025.

Key voting results included approvals and withholds for each director, varying in numbers, with high non-votes throughout. The meeting also addressed an exemption related to the Toronto Stock Exchange, utilizing Section 602.1 of the TSX Company Manual due to the company's NYSE inter-listing.

The detailed final voting results on all matters will be submitted to the U.S. Securities and Exchange Commission and will be accessible on the Company's SEDAR profile as well as on their website.